Economic Indicators - In January, the U.S. non-farm payrolls exceeded expectations, adding 130,000 jobs, with the unemployment rate dropping to 4.3%[4] - The U.S. labor market remains focused on recruitment contraction, with layoff intentions rising but actual layoffs not yet widespread[4] Market Reactions - U.S. stock markets reacted negatively to strong employment data, with the Dow Jones falling 66 points (0.13%) to close at 50,121 points, ending a three-day rally[9] - European markets showed mixed results, with the UK FTSE 100 reaching a new high, while the German DAX and French CAC 40 indices declined[9] Commodity and Currency Movements - Nickel prices rose by 2.23% to $17,880 per ton due to Indonesia's significant reduction in nickel production quotas from 42 million tons to 12 million tons[27] - Crude oil prices increased, with NYMEX crude oil rising 1.05% to $64.63 per barrel amid geopolitical tensions in Iran[27] Investment Insights - T-Mobile reported a 10% year-over-year increase in service revenue for Q4 2025, driven by a strong postpaid customer base, and raised its growth guidance[7] - Xiaomi's January vehicle deliveries fell to 39,000 units, down from over 50,000 in December, as the company prepares for the launch of its new SU7 model in April 2026[13] Bond Market Trends - The U.S. Treasury yields rose following the strong employment report, with the 10-year yield increasing by 3 basis points to 4.17%[30] - Asian investment-grade bond spreads widened by 2-3 basis points, reflecting a sell-off in Australian, Japanese, and Korean bonds[30]

Summary of Conference Call on Medical Aesthetics Industry Industry Overview - The medical aesthetics industry experienced fluctuations in data and trends from the second half of last year to January this year, with overall GMV and revenue slowing down after the second quarter, particularly showing negative growth in the third quarter, but recovering in the fourth quarter [1][2] - The growth in customer traffic is primarily driven by returning customers, with an increase in the proportion of new customers, especially among the younger demographic [2][4] Key Insights - **Revenue Trends**: The industry saw a 5% revenue growth in 2025 compared to 2020, with a 9% increase in customer traffic, although the average transaction value decreased by 4% [3][21] - **Quarterly Performance**: Q4 showed significant revenue growth of 10%, compensating for the low growth in Q2 and Q3, with January's revenue growth exceeding 10% [3][21] - **Customer Composition**: The proportion of returning customers increased from 52% to 58%, with new customer growth driven by new product launches and promotional activities [5][25] - **Product Growth**: New products, particularly botulinum toxin and collagen products, especially recombinant collagen, show growth potential [2][21] Tax Policy Impact - The adjustment of the VAT policy, with medical aesthetics services now subject to a 6% VAT, has impacted industry costs, although institutions are adopting strategies to mitigate this burden [10][28] - The termination of the medical aesthetics tax refund policy in South Korea is expected to benefit the domestic market, as it may encourage consumers to choose local services over traveling abroad [11][29] Product Line Analysis - **Botulinum Toxin Sales**: Sales of botulinum toxin products grew by 25% in 2023 compared to 2022, with a projected growth of 10% in 2025 [6][27] - **Collagen Products**: Sales of collagen products showed varied performance, with some brands experiencing significant growth, such as a 55% increase in sales for certain products in 2025 [12][29] - **Market Acceptance**: New botulinum products are well-received in the market, with institutions willing to adopt them due to their cost-effectiveness and ease of use [8][27] Competitive Landscape - The competition among leading medical aesthetics institutions is intensifying, with varying revenue trends observed among them [4][21] - The market is seeing a trend towards consolidation, with expectations of increased concentration in the industry as smaller institutions may struggle to compete [18][33] Future Outlook - The industry is expected to continue evolving with a focus on light medical aesthetics and increased institutional concentration, prompting companies to adjust their business strategies accordingly [2][21] - The introduction of new products and promotional strategies is anticipated to drive growth, with a target of achieving a 15% growth rate in 2026 [17][31] Additional Considerations - The acceptance and market potential of PDRN salmon needle products are being closely monitored, with expectations for rapid growth following regulatory approvals [14][30] - The overall market dynamics indicate a shift towards more standardized services and data-driven customer management, which may further influence the competitive landscape [33]

Core Insights - The Korean medical beauty industry is experiencing significant growth, with a projected increase in foreign patients visiting for treatments, particularly from China and Japan [4][5][6] - The cancellation of the tax refund policy for foreign patients raises concerns about the attractiveness of Korea as a medical tourism destination [1][6] - The competitive pricing and advanced technology in Korean medical beauty services continue to draw consumers, especially from China [2][3][4] Group 1: Market Growth and Trends - In 2024, the number of foreign patients seeking medical treatment in Korea is expected to reach nearly 1.2 million, a 93.2% increase from previous years [4] - The skin care sector is the most sought-after, with 705,000 patients, accounting for 56.6% of total foreign medical visits [4] - The Korean medical beauty market was valued at $572.14 million in 2023 and is projected to grow to $1.14 billion by 2029, with a compound annual growth rate of 12.29% [6] Group 2: Consumer Behavior and Preferences - Many young consumers are opting for "medical beauty weekends," traveling to Korea for quick procedures due to the perceived cost-effectiveness and advanced technology [2][3] - The average cost of procedures in Korea is significantly lower than in China, with some treatments costing only one-third of the price in Japan [5][6] - The presence of multilingual staff and tailored services for foreign patients enhances the overall experience, making it easier for non-Korean speakers to navigate the process [2][3] Group 3: Challenges and Concerns - The recent decision to eliminate the 10% tax refund for foreign patients may lead to a decline in visitor numbers, as this was a key factor in attracting international clients [6][7] - There are safety concerns and potential pitfalls in the medical beauty industry, including price transparency issues and the risk of inadequate pre- and post-operative care [7][8] - The disparity in quality among medical institutions, with many high-quality services concentrated in specific areas like Gangnam, poses challenges for consumers seeking reliable treatments [7][8]